CRISPR Therapeutics AG
CRSP
Jodie read · what matters now
Revenue reached $10.2 million, but operating cash use increased by $24.6 million as a prior milestone payment dropped out of the comparison.
The story is only the start. Jodie keeps watching the filing evidence, the companies connected to CRSP, and whether its market group begins moving.
Who this business touches
The relationships behind CRSP
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
Depended on by
Filing peers
Companies whose filings use similar operating language.
You can see the shape of the network here. Pro opens 28 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →
What is moving around it
Live connections
CRSP is currently a Leader in the organic co-movement group Gene Editing Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
Theme membership history
No durable theme membership has been observed for this name yet.